Takuya Ando
Nagoya City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takuya Ando.
Clinical Cancer Research | 2006
Nobuyoshi Sugito; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Takuya Ando; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii
Purpose: MicroRNAs (miRNA) are small noncoding RNAs thought to be involved in physiologic and developmental processes by negatively regulating the expression of target genes. Little is known about the role of miRNAs in normal and cancer cells. It is possible that deregulation of miRNA may contribute to the oncogenesis of some cancers. We studied the expression level of the miRNA processing enzyme (DICER1, DGCR8, and RNASEN) in esophageal squamous cell carcinoma (ESCC). Experimental Design: The expression levels of DICER1, DGCR8, and RNASEN mRNA in 73 ESCC tissues were compared with that in corresponding normal esophageal epithelium by Taqman real-time reverse-transcription PCR. We also examined RNASEN protein expression in 27 cell lines. The role of RNASEN in cell proliferation in ESCC cells was assessed by small interfering RNA. Paraffin sections of ESCC patients were immunohistochemically investigated. Results: We found that RNASEN expression levels were enhanced in a fraction of esophageal cancers. Multivariate Cox regression analysis showed that the prognostic effect of RNASEN (P = 0.0036) seems to be independent of disease stage (P = 0.0060). Knockdown of RNASEN in esophageal cancer cell lines resulted in a 46% to 85% reduction in cell number. In an immunohistochemical study, the intensity of RNASEN expression was often increased in the tumor compared with that in normal epithelium. Conclusions: The relationship between the RNASEN expression and the prognosis of the ESCC patients warrants a further study on the role of miRNA and tumor progression.
Diseases of The Esophagus | 2008
Takuya Ando; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Nobuyoshi Sugito; Ryota Mori; Ryo Ogawa; Takeyasu Katada; Yoshitaka Fujii
5-Fluorouracil (5-FU) is a key drug in the treatment of esophageal squamous cell carcinoma (ESCC). Gene expression of 5-FU metabolic enzymes such as thymidylate synthase (TS), thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD) and orotate phosphoribosyl transferase (OPRT), has recently been investigated in order to predict the 5-FU sensitivity of several cancers. We examined the relationship between such gene expression and 5-FU sensitivity in 25 ESCC cell lines. TS, DPD, TP and OPRT mRNA levels were assessed by real-time polymerase chain reaction. The 50% inhibitory concentrations (IC50) of 5-FU in 25 ESCC cell lines were determined by cell proliferation assay. IC50 values for 5-FU ranged from 1.00 to 39.81 micromol/L. There were significant positive correlations between IC50 and TS mRNA expression (R(2) = 0.5781, P < 0.0001) and DPD mRNA expression (R(2) = 0.3573, P = 0.0016). There were no correlations between IC50 and TP or OPRT mRNA expression. TS and DPD mRNA expression levels may be useful indicators in predicting the anti-tumor activity of 5-FU in ESCC.
Journal of The American College of Surgeons | 2014
Masahiro Kimura; Yoshiyuki Kuwabara; Hideyuki Ishiguro; Takuya Ando; Ryo Ogawa; Midori Shiozaki; Tatsuya Tanaka; Hiromitsu Takeyama
One factor influencing surgery for esophageal cancer is the reconstruction technique, which may involve constructing a tube from the stomach or the intestines. Good blood flow and adequate length are necessary. Gastric tube formation became easier with the availability of improved surgical staplers, but gastric tube necrosis and leakage may still occur. Therefore, a simple technique providing good blood flow to the end of the gastric tube is needed. One method is called the whole stomach technique: the surgeon excises the small part of the gastric wall supplied by the left gastric artery. Another is called the gastric tube technique: the surgeon divides the stomach from the lesser curvature along the axis of the greater curvature. But the gastric tube method is so difficult that different devices are used in each institution. We use the gastric tube method, except in patients with gastric cancer or patients with a history of gastrectomy. One reason for choosing this method is that it provides sufficient length. Length is never a problem, even in the case of laryngo-esophagotomy. With a linear cutting stapler, shaping the gastric tube is comparatively easy and time-saving. Since 2012, we have used the EndoGIA60 with Tri-Staple (Covidien Japan). To shape a long, slender tube, we usually use 6 or 7 linear staplers. The first problem is an irregular section of a knot, which causes no trouble if the serial stapling is in the same direction (Fig. 1). But once the direction shifts, inserting a linear stapler becomes difficult, and the knot becomes more notched. To shape a long tube, the first 2 staplers must be at a nearly right angle. If the area below is the remaining side, the section is more notched. These sides are vulnerable, with limited blood flow. Therefore, we developed a new technique using 2 types of staplers.
Oncology Reports | 2007
Takuya Ando; Hideyuki Ishiguro; Masahiro Kimura; Akira Mitsui; Yoichiro Mori; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Koshiro Harada; Takeyasu Katada; Ryo Ogawa; Yoshitaka Fujii; Yoshiyuki Kuwabara
Diseases of The Esophagus | 2006
Takuya Ando; H. Ishiguro; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Y. Fujii; Yoshiyuki Kuwabara
Oncology Reports | 2006
Nobuhiro Takashima; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Nobuhiro Haruki; Takuya Ando; Hiroki Kurehara; Nobuyoshi Sugito; Ryota Mori; Yoshitaka Fujii
International Journal of Oncology | 2007
Hiroki Kurehara; Hideyuki Ishiguro; Masahiro Kimura; Akira Mitsui; Takuya Ando; Nobuyoshi Sugito; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii; Yoshiyuki Kuwabara
Oncology Reports | 2006
Takuya Ando; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Hiroki Kurehara; Nobuyoshi Sugito; Keisuke Tomoda; Ryota Mori; Nobuhiro Takashima; Ryo Ogawa; Yoshitaka Fujii
Journal of The American College of Surgeons | 2004
Yoshiyuki Kuwabara; Noriyuki Shinoda; Atsushi Sato; Masahiro Kimura; Hideyuki Ishiguro; Hironori Sugiura; Tadashi Tanaka; Takuya Ando; Y. Fujii; Yoshitaka Fujii
Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 2001
Takuya Ando; Kenichi Sakakibara; Hideki Tsuzi; Naoki Nishiwaki; Kotaro Mizuno; Shigemitsu Ando; Nobuyuki Miyake; Kazuhiro Tashiro